Cargando…

Editorial: Acute phase proteins as biomarkers and therapeutics in acute and chronic inflammatory conditions

Detalles Bibliográficos
Autores principales:	Stanke, Frauke, Janciauskiene, Sabina, Olejnicka, Beata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932952/ https://www.ncbi.nlm.nih.gov/pubmed/36817143 http://dx.doi.org/10.3389/fphar.2023.1145990

Ejemplares similares

The Multifaceted Effects of Alpha1-Antitrypsin on Neutrophil Functions
por: Janciauskiene, Sabina, et al.
Publicado: (2018)

Indirect effect of alpha-1-antitrypsin on endotoxin-induced IL-1β secretion from human PBMCs
por: Janciauskiene, Sabina, et al.
Publicado: (2022)

Heme as a Target for Therapeutic Interventions
por: Immenschuh, Stephan, et al.
Publicado: (2017)

Targeting Proteinase Activated Receptor-4 Reduces Mechanonociception During the Acute Inflammatory Phase but not the Chronic Neuropathic Phase of Osteoarthritis in Rats
por: O’Brien, Melissa S., et al.
Publicado: (2021)

Potential Roles of Acute Phase Proteins in Cancer: Why Do Cancer Cells Produce or Take Up Exogenous Acute Phase Protein Alpha1-Antitrypsin?
por: Janciauskiene, Sabina, et al.
Publicado: (2021)

Boosted Pro-Inflammatory Activity in Human PBMCs by Lipopolysaccharide and SARS-CoV-2 Spike Protein Is Regulated by α-1 Antitrypsin †
por: Tumpara, Srinu, et al.
Publicado: (2021)

The Relationship between Plasma Alpha-1-Antitrypsin Polymers and Lung or Liver Function in ZZ Alpha-1-Antitrypsin-Deficient Patients
por: Sark, Annelot D., et al.
Publicado: (2022)

Beneficial effects of alpha-1 antitrypsin therapy in a mouse model of colitis-associated colon cancer
por: Al-Omari, Mariam, et al.
Publicado: (2023)

Editorial: Traditional medicine and chronic inflammatory diseases
por: Liu, Wei, et al.
Publicado: (2023)

Editorial: Platelets in Disease: From Biomarkers Discovery to Therapeutic Targets
por: Zhao, Fan, et al.
Publicado: (2022)

Gene Mutations as Emerging Biomarkers and Therapeutic Targets for Relapsed Acute Myeloid Leukemia
por: Aziz, Habsah, et al.
Publicado: (2017)

Editorial: Recent advances in novel therapeutic molecules and targets for inflammatory diseases
por: Li, Feng, et al.
Publicado: (2023)

Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function
por: Waschki, Benjamin, et al.
Publicado: (2017)

Comprehensive Analysis of Chemical Structures That Have Been Tested as CFTR Activating Substances in a Publicly Available Database CandActCFTR
por: Nietert, Manuel Manfred, et al.
Publicado: (2021)

Plasma Acute Phase Proteins as Predictors of Chronic Lung Allograft Dysfunction in Lung Transplant Recipients
por: Janciauskiene, Sabina, et al.
Publicado: (2020)

Editorial: Autoimmune and Inflammatory Rheumatic Diseases: Identifying Biomarkers of Response to Therapy With Biologics
por: Giuliani, Anna Lisa, et al.
Publicado: (2021)

Editorial: The Canonical and Non-Canonical Endocannabinoid System as a Target in Cancer and Acute and Chronic Pain
por: Contino, Marialessandra, et al.
Publicado: (2020)

Effect of Alpha-1 Antitrypsin on CFTR Levels in Primary Human Airway Epithelial Cells Grown at the Air-Liquid-Interface
por: Stanke, Frauke, et al.
Publicado: (2021)

Editorial: Anti-inflammatory immunopharmacology in the prevention and treatment of major chronic diseases
por: Zhang, Qiuwang, et al.
Publicado: (2023)

Editorial: Natural compounds regulating epigenetics for treating chronic inflammatory diseases
por: Zhang, Mingyu, et al.
Publicado: (2023)

Editorial: Development of novel small molecules as therapeutics for inflammatory diseases and delineating their molecular mechanisms
por: Ramprasath, Tharmarajan, et al.
Publicado: (2022)

A Novel Mouse Monoclonal Antibody C42 against C-Terminal Peptide of Alpha-1-Antitrypsin
por: Tumpara, Srinu, et al.
Publicado: (2021)

Editorial: Investigating the molecular targets and therapeutic potential of Withania somnifera (Ashwagandha) in various pathophysiological conditions
por: Dar, Nawab John, et al.
Publicado: (2023)

Editorial: Inflammation and aging in chronic and degenerative diseases: Current and future therapeutic strategies
por: Falzone, Luca, et al.
Publicado: (2023)

Editorial: Autoimmune and inflammatory rheumatic diseases: Identifying biomarkers of response to therapy with biologics: Volume II
por: Giuliani, Anna Lisa, et al.
Publicado: (2023)

Editorial: Harnessing chemotherapy resistance and development of novel therapeutic strategies for acute leukemia with KMT2A (MLL)-gene rearrangements
por: Esposito, Maria Teresa, et al.
Publicado: (2022)

Editorial: Protein-based nanocarriers for delivery of nutraceutical, diagnostic and therapeutic agents
por: Zhong, Jian, et al.
Publicado: (2022)

Editorial: Biomarkers in Drug Hypersensitivity
por: Agúndez, José A. G., et al.
Publicado: (2017)

Immunophenotyping of Acute Inflammatory Exacerbations of Lung Injury Driven by Mutant Surfactant Protein-C: A Role for Inflammatory Eosinophils
por: Nguyen, Jacklyn, et al.
Publicado: (2022)

Ectonucleotidases in Acute and Chronic Inflammation
por: Giuliani, Anna Lisa, et al.
Publicado: (2021)

Analgesic and Anti-Inflammatory Effects of Perampanel in Acute and Chronic Pain Models in Mice: Interaction With the Cannabinergic System
por: De Caro, Carmen, et al.
Publicado: (2021)

Editorial: Novel biomarkers for anticancer therapy
por: Wang, Ting, et al.
Publicado: (2023)

Evaluation of Prophylactic and Therapeutic Effects of Tramadol and Tramadol Plus Magnesium Sulfate in an Acute Inflammatory Model of Pain and Edema in Rats
por: Srebro, Dragana, et al.
Publicado: (2018)

Human PBMCs Form Lipid Droplets in Response to Spike Proteins
por: Sivaraman, Kokilavani, et al.
Publicado: (2023)

Editorial: Sex Differences in Inflammatory Diseases
por: Trabace, Luigia, et al.
Publicado: (2022)

Acute Phase Proteins as Early Predictors for Immunotherapy Response in Advanced NSCLC: An Explorative Study
por: Schneider, Marc A., et al.
Publicado: (2022)

Editorial: Therapeutic implications of circadian rhythms
por: Yang, Guangrui, et al.
Publicado: (2015)

Editorial: Therapeutic Advances in Melatonin Research
por: López-Muñoz, Francisco, et al.
Publicado: (2022)

Editorial: Plant products for antiviral therapeutics
por: Mandal, Anirban, et al.
Publicado: (2022)

Editorial: Prodrug design and therapeutic applications
por: Xiao, Qicai, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_un1lv70vdo2vof2uq136c7l831